Xilio Therapeutics Inc at Morgan Stanley Global Healthcare Conference Transcript
Good afternoon, everyone, and thanks for joining us for the Morgan Stanley Global Healthcare Conference. I'm Mike Ulz, one of the biotech analyst here. And it's my pleasure to introduce Marty Huber, President from Xilio Therapeutics.
Just a reminder, the format for today is a fireside chat. But before we get into Q&A, I need to read a quick disclaimer. So for important disclosures, please see the Morgan Stanley research disclosure website at www.morganstanley.com/researchdisclosures. If you have any questions, please reach out to your Morgan Stanley sales representative.
Questions & Answers
And with that, Marty, thanks for being here. And maybe just to start off, since not everyone might be familiar with your platform, if you can talk about GPS or your geographically precise solutions, and how that actually works.
Access to All Earning Calls and Stock Analysis | |
30-Year Financial on one screen | |
All-in-one Stock Screener with unlimited filters | |
Customizable Stock Dashboard | |
Real Time Insider Trading Transactions | |
8,000+ Institutional investors’ 13F holdings | |
Powerful Excel Add-in and Google sheets Add-on | |
All data downloadable | |
Quick customer support | |
And much more... |